Search / Trial NCT06231160

Clinical Comparative Study of Systematic Therapy Combined With MWA and Systematic Therapy for Pancreatic Cancer

Launched by CHINESE PLA GENERAL HOSPITAL · Jan 21, 2024

Trial Information

Current as of October 09, 2024

Not yet recruiting

Keywords

Description

Pancreatic carcinoma (PC) is the deadliest malignant tumors worldwide. Surgical resection is one of the most effective methods for the treatment of PC, but the resectable rate is less than 20% among the patients with PCs, and the recurrent and metastatic rate is more than 80% in two years after resection. Furthermore, it is difficult to achieve tumoral complete responses by traditional therapies including chemotherapy, radiotherapy and transarterial embolization. Ablation has been confirmed one of the most effective methods for solid tumors by recent twenty years and proven to be a radical ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Inoperable pancreatic cancer
  • * Age from 18 to 80
  • * PS score from 0 to 3
  • * Clear pathological diagnosis
  • Exclusion Criteria:
  • * Severe coagulation dysfunction
  • * Individuals with severe heart, lung, liver, and kidney dysfunction
  • * Individuals with acute or active infectious lesions in any part of the body
  • * Researchers believe that there are any other factors that are not suitable for inclusion or that affect the participation of participants in the study
  • * Psychological health issues that hinder this experiment

About Chinese Pla General Hospital

The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0